3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Oropharyngeal Neoplasms
4
Head and Neck Neoplasms
3
Lung Neoplasms
2
Glioblastoma
2
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Neoplasms
1
Rectal Malignant Neoplasms
1
Radiation Injuries
1
Postoperative Complications
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Mouth Neoplasms
1
Low Anterior Resection Syndrome
1
Laryngeal Neoplasms
1
Infiltrating Bladder Urothelial Carcinoma
1
HPV-Related Squamous Cell Carcinoma
1
Fatigue
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Interventions
Fulvestrant
63
Letrozole
53
Paclitaxel
49
Trastuzumab
41
pembrolizumab
40
ribociclib
37
Specimen Handling
37
palbociclib
36
Capecitabine
34
Carboplatin
33
Anastrozole
33
Tamoxifen
32
exemestane
29
pertuzumab
28
abemaciclib
28
Magnetic Resonance Spectroscopy
26
Cyclophosphamide
26
trastuzumab deruxtecan
24
Surveys and Questionnaires
21
Radiotherapy
18
Biopsy
18
olaparib
17
Standard of Care
16
Docetaxel
16
Blood Specimen Collection
16
Taxes
14
Mastectomy, Segmental
14
eribulin
13
elacestrant
13
130-nm albumin-bound paclitaxel
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Chemoradiotherapy
×
90 days
×
Clear all
No trials found.